JOURNAL OF INTERNATIONAL ADVANCED OTOLOGY, cilt.10, sa.3, ss.205-210, 2014 (SCI-Expanded)
OBJECTIVE: To investigate the potential protective effect of recombinant human erythropoietin (rhEPO) against cisplatin-induced ototoxicity.